| Product Code: ETC10600674 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Finland continued to rely heavily on imports of human insulin drugs and delivery devices, with top exporters including the USA, Germany, UK, Austria, and New Zealand. The market concentration, as indicated by the Herfindahl-Hirschman Index (HHI), remained very high, reflecting the dominance of these key players. Despite a high compound annual growth rate (CAGR) of 24.17% from 2020 to 2024, there was a notable decline in growth rate from 2023 to 2024 (-20.18%). This data suggests a dynamic market landscape with potential shifts in the import trends for these crucial healthcare products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Finland Human Insulin Drugs and Delivery Devices Market Overview |
3.1 Finland Country Macro Economic Indicators |
3.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, 2021 & 2031F |
3.3 Finland Human Insulin Drugs and Delivery Devices Market - Industry Life Cycle |
3.4 Finland Human Insulin Drugs and Delivery Devices Market - Porter's Five Forces |
3.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Insulin Type, 2021 & 2031F |
3.6 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Delivery Device, 2021 & 2031F |
3.7 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.8 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Patient Demographic, 2021 & 2031F |
3.9 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume Share, By Treatment Goal, 2021 & 2031F |
4 Finland Human Insulin Drugs and Delivery Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Finland Human Insulin Drugs and Delivery Devices Market Trends |
6 Finland Human Insulin Drugs and Delivery Devices Market, By Types |
6.1 Finland Human Insulin Drugs and Delivery Devices Market, By Insulin Type |
6.1.1 Overview and Analysis |
6.1.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Type, 2021 - 2031F |
6.1.3 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Rapid-Acting Insulin, 2021 - 2031F |
6.1.4 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-Acting Insulin, 2021 - 2031F |
6.1.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Pre-mixed Insulin, 2021 - 2031F |
6.1.6 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Glargine, 2021 - 2031F |
6.2 Finland Human Insulin Drugs and Delivery Devices Market, By Delivery Device |
6.2.1 Overview and Analysis |
6.2.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pens, 2021 - 2031F |
6.2.3 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps, 2021 - 2031F |
6.2.4 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Syringes, 2021 - 2031F |
6.2.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Insulin Pumps/Pens, 2021 - 2031F |
6.3 Finland Human Insulin Drugs and Delivery Devices Market, By Formulation Type |
6.3.1 Overview and Analysis |
6.3.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.3 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.4 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.3.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Injectable, 2021 - 2031F |
6.4 Finland Human Insulin Drugs and Delivery Devices Market, By Patient Demographic |
6.4.1 Overview and Analysis |
6.4.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.4.3 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.4.4 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Children, Adults, 2021 - 2031F |
6.4.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Elderly Population, 2021 - 2031F |
6.5 Finland Human Insulin Drugs and Delivery Devices Market, By Treatment Goal |
6.5.1 Overview and Analysis |
6.5.2 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Blood Sugar Control, 2021 - 2031F |
6.5.3 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Long-term Glycemic Control, 2021 - 2031F |
6.5.4 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Immediate Blood Sugar Regulation, 2021 - 2031F |
6.5.5 Finland Human Insulin Drugs and Delivery Devices Market Revenues & Volume, By Overnight Glucose Control, 2021 - 2031F |
7 Finland Human Insulin Drugs and Delivery Devices Market Import-Export Trade Statistics |
7.1 Finland Human Insulin Drugs and Delivery Devices Market Export to Major Countries |
7.2 Finland Human Insulin Drugs and Delivery Devices Market Imports from Major Countries |
8 Finland Human Insulin Drugs and Delivery Devices Market Key Performance Indicators |
9 Finland Human Insulin Drugs and Delivery Devices Market - Opportunity Assessment |
9.1 Finland Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Insulin Type, 2021 & 2031F |
9.2 Finland Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Delivery Device, 2021 & 2031F |
9.3 Finland Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.4 Finland Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Patient Demographic, 2021 & 2031F |
9.5 Finland Human Insulin Drugs and Delivery Devices Market Opportunity Assessment, By Treatment Goal, 2021 & 2031F |
10 Finland Human Insulin Drugs and Delivery Devices Market - Competitive Landscape |
10.1 Finland Human Insulin Drugs and Delivery Devices Market Revenue Share, By Companies, 2024 |
10.2 Finland Human Insulin Drugs and Delivery Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |